HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Testa-Fernández Selected Research

Cyclophilin C

1/2022Increase of serum cyclophilin C levels in the follow-up of coronary artery disease: A biomarker and possible clinical predictor.
1/2019High Serum Cyclophilin C levels as a risk factor marker for Coronary Artery Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Testa-Fernández Research Topics

Disease

2Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2019
2Aortic Valve Stenosis (Aortic Stenosis)
01/2019 - 01/2019
2Ischemia
04/2012 - 07/2011
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Chronic Obstructive Pulmonary Disease (COPD)
01/2016
1Atrial Fibrillation
04/2012

Drug/Important Bio-Agent (IBA)

2Cyclophilin CIBA
01/2022 - 01/2019
2Insulin (Novolin)FDA Link
01/2019 - 01/2019
1Biomarkers (Surrogate Marker)IBA
01/2022
1ImmunophilinsIBA
01/2019
1Cyclophilins (Cyclophilin)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Fibrinogen (Factor I)FDA Link
01/2016
12'- methylspiro- (1- azabicyclo(2.2.2.)octane- 3,4'- (1,3)- dioxolane) (AF-30)IBA
04/2012
1Nitroglycerin (Dynamite)FDA LinkGeneric
07/2011